UCL Technology Fund
VC Fund
London, United Kingdom
UCL Technology Fund is a VC fund in London focused on Biotechnology and Health Care. The UCL Technology Fund is dedicated to investing in intellectual property commercialisation opportunities arising from UCL’s world-class research base, focusing in particular on the physical and life sciences. The Fund supports UCL in achieving the full potential of innovations that have prospects for outstanding societal and market impact, rightthrough the development journey from initial proof of concept to practical commercial application.
- Total investments:
- 44
- Last investment:
- Lead investor:
- 45%
- Fund size:
- $127M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries UCL Technology Fund invests in
Stages UCL Technology Fund invests in
Countries UCL Technology Fund invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Seed
- $1M–$10M
- Series A
- $5.3M–$84M
- Series B
- $47M–$139M
Investment Focus
Industry
- Biotechnology 9 (20%)
- Health Care 6 (14%)
- Artificial Intelligence 5 (11%)
- Manufacturing 4 (9%)
- Machine Learning 4 (9%)
Stage
- Seed 15 (34%)
- Series A 11 (25%)
- Series B 4 (9%)
- Pre-Seed 3 (7%)
- Funding Round 3 (7%)
Country
- United Kingdom 25 (57%)
- United States 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
David Grimm
Investment Director
|
Investment Director | Total investments: 14 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Gaussion
|
Gaussion is revolutionising batteries by utilising magneto-electrochemistry. | $27.8M / Series A / Jun 29, 2026 | |
Gigaton
|
Gigaton is a climate technology company developing artificial intelligence to decarbonize energy-intensive industries. It intends to use AI technology to reduce carbon emissions by gigatonnes per year. Its emphasis is on energy-intensive industries like cement, steel, and glass, which account for more than 20% of global emissions. Deep learning isused by Carbon Re's Delta Zero platform for industrial decarbonization to enable rapid development and deployment of new low-carbon industrial processes, designs, and materials. | $26M / Series A / Jun 02, 2026 | |
Oriole Networks
|
Oriole Networks is a new company that improve the performance of AI systems and speed up data centers while substantially lowering energy usage for a more sustainable future. | $22M / Series A / Oct 21, 2024 | |
|
Gaussion
|
Gaussion is revolutionising batteries by utilising magneto-electrochemistry. | $11.9M / Series A / Aug 12, 2024 | |
EpilepsyGTx
|
EpilepsyGTx is a late-stage biotech company exploring cutting-edge gene therapies to improve the management of focal refractory epilepsy (FRE). | $10M / Seed / Jun 24, 2024 | |
|
Oriole Networks
|
Oriole Networks is a new company that improve the performance of AI systems and speed up data centers while substantially lowering energy usage for a more sustainable future. | $12.6M / Seed / Mar 27, 2024 | |
Stanhope AI
|
Stanhope AI teaches robots and machines how to make decisions in the real world, with a particular focus on allowing them to tackle situations in which they have received no training. | $2.9M / Seed / Mar 20, 2024 | |
|
Stanhope AI
|
Stanhope AI teaches robots and machines how to make decisions in the real world, with a particular focus on allowing them to tackle situations in which they have received no training. | $2.9M / Seed / Mar 20, 2024 | |
Stanhope
|
Stanhope creates and delivers major commercial and mixed-use developments in London and the South East. | $2.3M / Seed / Mar 19, 2024 | |
Echopoint Medical
|
Echopoint Medical Ltd is developing a family of optical-fibre based sensors which integrate into medical innovative devices: bringing unparalleled sensing modalities to minimally-invasive procedures.Echopoint Medical Ltd (EML) is a medical device company focused on transforming precision diagnosis and treatment of cardiovascular disease. A spin-outfrom the University College London, we are translating breakthroughs in fibre optic sensor technology to address key unmet needs of patients, clinicians, and healthcare providers. | $5.3M / Series A / Feb 20, 2024 | |
| See all 44 investments → | |||
Co-Investors
AlbionVC
7 deals together
London Co-Investment Fund
7 deals together
Parkwalk Advisors
7 deals together
Syncona Partners LLP
6 deals together
BGF Ventures
5 deals together
Clean Growth Fund
5 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does UCL Technology Fund invest in?
UCL Technology Fund invests primarily in Biotechnology, Health Care and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 44 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is UCL Technology Fund's check size?
UCL Technology Fund typically joins rounds of $1M–$10M at Seed, $5.3M–$84M at Series A and $47M–$139M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds UCL Technology Fund participates in.
How do I contact UCL Technology Fund?
Public channels for UCL Technology Fund include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at UCL Technology Fund?
The team at UCL Technology Fund includes David Grimm (Investment Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
